These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38300900)

  • 1. The "basics" of HIV-1 assembly.
    Sumner C; Ono A
    PLoS Pathog; 2024 Feb; 20(2):e1011937. PubMed ID: 38300900
    [No Abstract]   [Full Text] [Related]  

  • 2. Reactivation of Latent HIV-1 via AID/APOBEC.
    José DP; Geddes VEV; Tanuri A; Aguiar RS
    AIDS Res Hum Retroviruses; 2020 Oct; 36(10):793-794. PubMed ID: 32668961
    [No Abstract]   [Full Text] [Related]  

  • 3. The C-Terminal End of HIV-1 Vpu Has a Clade-Specific Determinant That Antagonizes BST-2 and Facilitates Virion Release.
    Sharma S; Jafari M; Bangar A; William K; Guatelli J; Lewinski MK
    J Virol; 2019 Jun; 93(11):. PubMed ID: 30867310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human immunodeficiency virus-indeterminate western blot and abortive infection.
    Jackson JB
    Transfusion; 1997 Jan; 37(1):1-2. PubMed ID: 9024481
    [No Abstract]   [Full Text] [Related]  

  • 5. Immature HIV-1 assembles from Gag dimers leaving partial hexamers at lattice edges as potential substrates for proteolytic maturation.
    Tan A; Pak AJ; Morado DR; Voth GA; Briggs JAG
    Proc Natl Acad Sci U S A; 2021 Jan; 118(3):. PubMed ID: 33397805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 and HIV-2 seropositivity among female sex workers in the Tenere Desert, Niger.
    Gragnic G; Julvez J; Abari A; Alexandre Y
    Trans R Soc Trop Med Hyg; 1998; 92(1):29. PubMed ID: 9692142
    [No Abstract]   [Full Text] [Related]  

  • 7. Intersection of immune checkpoints and CD8+ T cell noncytolytic suppression of HIV-1 infection: putting on the brakes versus the nuclear option.
    Zaunders J
    AIDS; 2019 Mar; 33(3):581-583. PubMed ID: 30702523
    [No Abstract]   [Full Text] [Related]  

  • 8. [Silent HIV infection in HIV seronegative individuals?].
    Waldum HL; Iversen OJ
    Tidsskr Nor Laegeforen; 1990 Mar; 110(8):997-8. PubMed ID: 2181734
    [No Abstract]   [Full Text] [Related]  

  • 9. A cure for HIV: how would we know?
    Zerbato JM; Lewin SR
    Lancet HIV; 2020 May; 7(5):e304-e306. PubMed ID: 32169159
    [No Abstract]   [Full Text] [Related]  

  • 10. Show your cap or be packaged into HIV-1.
    Levin JG; Rein A
    Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34583998
    [No Abstract]   [Full Text] [Related]  

  • 11. Determining the longevity and dynamics of HIV-1 neutralizing activity.
    Nat Med; 2023 Nov; 29(11):2720-2721. PubMed ID: 37957380
    [No Abstract]   [Full Text] [Related]  

  • 12. HIV-1 Control and Immunoglobulin Genes.
    Pandey JP
    J Infect Dis; 2018 Mar; 217(7):1170. PubMed ID: 29346629
    [No Abstract]   [Full Text] [Related]  

  • 13. HAART for HIV-1 infection: zeroing in on when to start: comment on "Timing of HAART initiation and clinical outcomes in human immunodeficiency virus type 1 seroconverters".
    Kuritzkes DR
    Arch Intern Med; 2011 Sep; 171(17):1569-70. PubMed ID: 21949166
    [No Abstract]   [Full Text] [Related]  

  • 14. Correspondence: behavioural changes following HIV seroconversion during the historical expansion of HIV treatment in the United States.
    Skerritt L; Boileau NT
    AIDS; 2019 May; 33(6):1102-1103. PubMed ID: 30946168
    [No Abstract]   [Full Text] [Related]  

  • 15. Addressing Antiretroviral Drug Resistance with Host-Targeting Drugs-First Steps towards Developing a Host-Targeting HIV-1 Assembly Inhibitor.
    Lingappa JR; Lingappa VR; Reed JC
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33802145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 from a seronegative transplant donor.
    Clerici M; Berzofsky JA; Shearer GM; Giorgi JV; Tacket C
    N Engl J Med; 1992 Aug; 327(8):564-5. PubMed ID: 1635574
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to the letter to the editor: antibody-mediated control of HIV-1 through an alternative pathway.
    Green JA; Lum T
    AIDS; 2020 Mar; 34(4):645. PubMed ID: 32108674
    [No Abstract]   [Full Text] [Related]  

  • 18. Addressing HIV-1 latency with Flow-FISH: Finding, characterizing and targeting HIV-1 infected cells.
    Freen-van Heeren JJ
    Cytometry A; 2021 Sep; 99(9):861-865. PubMed ID: 34018663
    [No Abstract]   [Full Text] [Related]  

  • 19. Uptake of confidential, named HIV testing in Scottish prisons.
    Gore SM; Basson J; Bird AG; Goldberg DJ
    Lancet; 1992 Oct; 340(8824):907-8. PubMed ID: 1357310
    [No Abstract]   [Full Text] [Related]  

  • 20. The Esperanza Patient: More Hope for a Sterilizing HIV-1 Cure.
    Blankson JN
    Ann Intern Med; 2022 Jan; 175(1):135-136. PubMed ID: 34781716
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.